StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ANNX

Annexon, Inc.

ANNX Nasdaq Pharmaceutical Preparations EDGAR ↗
$5.25
-0.02 -0.38%

Key statistics

from XBRL data in SEC filings
Market cap
$1.02B
Revenue (TTM)
Net income (TTM)
-$196M
EPS (TTM)
$-1.20
P/E ratio
Dividend yield
Free cash flow
-$186M
Cash
$175M
Total assets
$263M
Gross margin
52-week range
$2.03 – $7.18

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Took on a direct financial obligation; Other events Jul 30, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Director or officer change Feb 17, 2026 8-K Regulation FD disclosure Jan 14, 2026 8-K Other events Jan 12, 2026 8-K Entered a material agreement; Other events Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Modified rights of security holders Jun 25, 2025 8-K Shareholder vote results Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Other events Jan 13, 2025 8-K Director or officer change; Regulation FD disclosure Jan 10, 2025 8-K Other events Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Other events Oct 22, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Other events Aug 5, 2024 8-K Other events Jun 25, 2024 8-K Shareholder vote results Jun 12, 2024 8-K Entered a material agreement; Other events Jun 7, 2024 8-K Regulation FD disclosure; Other events Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Other events May 7, 2024 10-K Fiscal year ended 2023-12-31 Mar 26, 2024 8-K Results of operations (earnings release) Mar 26, 2024 8-K Regulation FD disclosure Mar 4, 2024 8-K Regulation FD disclosure Jan 8, 2024